Encapsulated Resveratrol (RSV) Nanoparticles
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 19/004,832, filed Dec 30, 2024. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,447,131 | Encapsulated Resveratrol (RSV) Nanoparticles In force · High confidence | King Saud University | In force | High confidence | ||
| US 12,465,574 | Encapsulated Resveratrol (RSV) Nanoparticles In force · High confidence | King Saud University | In force | High confidence | ||
| US 12,521,353 | Encapsulated Resveratrol (RSV) Nanoparticles In force · High confidence | King Saud University | In force | High confidence | ||
| US 12,599,569 | Encapsulated Resveratrol (RSV) Nanoparticles In force · High confidence | King Saud University | In force | High confidence | ||
| US 12,544,340 | Encapsulated Resveratrol (RSV) Nanoparticles In force · High confidence | King Saud University | In force | High confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.